| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 139.06B | 139.58B | 166.14B | 181.01B | 154.41B | 134.77B |
| Gross Profit | 18.51B | 18.68B | 21.36B | 22.64B | 18.47B | 13.90B |
| EBITDA | 3.60B | 3.98B | 6.64B | 8.03B | 5.11B | 2.48B |
| Net Income | 2.08B | 2.44B | 5.01B | 5.49B | 3.58B | 1.79B |
Balance Sheet | ||||||
| Total Assets | 90.58B | 93.08B | 98.71B | 106.58B | 93.08B | 76.38B |
| Cash, Cash Equivalents and Short-Term Investments | 21.84B | 23.37B | 19.08B | 14.14B | 14.05B | 13.11B |
| Total Debt | 8.80B | 8.78B | 12.31B | 9.91B | 8.05B | 7.23B |
| Total Liabilities | 43.36B | 43.96B | 50.74B | 62.09B | 55.05B | 41.35B |
| Stockholders Equity | 47.22B | 49.11B | 47.97B | 44.48B | 38.02B | 35.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.04B | 4.11B | -619.00M | 609.00M | 1.54B |
| Operating Cash Flow | 0.00 | 9.10B | 4.23B | -545.00M | 792.00M | 1.59B |
| Investing Cash Flow | 0.00 | -389.00M | 883.00M | -731.00M | 244.00M | -141.00M |
| Financing Cash Flow | 0.00 | -5.22B | -608.00M | 906.00M | -580.00M | -309.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥188.34B | 4.98 | 17.09% | 2.94% | 9.67% | 45.58% | |
76 Outperform | ¥22.28B | 10.49 | ― | 3.83% | 41.87% | 167.99% | |
74 Outperform | ¥49.79B | 13.51 | ― | 4.12% | -4.88% | -26.05% | |
65 Neutral | ¥30.21B | -17.27 | ― | 5.16% | 1.71% | -29.37% | |
64 Neutral | ¥38.46B | 40.99 | 1.55% | 1.34% | -34.13% | -31.24% | |
64 Neutral | ¥14.79B | 25.64 | ― | 4.62% | -2.98% | 4.56% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |